Continuum Advisory, LLC Novartis Ag Transaction History

Continuum Advisory, LLC

$760 Million
Q4 2024

A detailed history of Continuum Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Continuum Advisory, LLC holds 1,021 shares of NVS stock, worth $113,821. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,021

Previous 926 10.26%

Holding current value

$113,821

Previous $106,000 6.6%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $9,194 - $11,132	95 Added 10.26%	1,021 $99,000
Q3 2024 Nov 15, 2024	SELL	$106.13 - $120.89 $11,568 - $13,177	-109 Reduced 10.53%	926 $106,000
Q2 2024 Jul 19, 2024	SELL	$92.57 - $107.37 $1,018 - $1,181	-11 Reduced 1.05%	1,035 $110,000
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $598,105 - $680,974	-6,278 Reduced 85.72%	1,046 $101,000
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $83,043 - $91,386	-900 Reduced 10.94%	7,324 $739,000
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $21,882 - $24,285	-231 Reduced 2.73%	8,224 $837,000
Q2 2023 Dec 13, 2023	BUY	$92.52 - $104.91 $64,486 - $73,122	697 Added 8.98%	8,455 $853,000
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $64,486 - $73,122	697 Added 8.98%	8,455 $853,000
Q1 2023 Dec 13, 2023	SELL	$80.03 - $92.81 $1,920 - $2,227	-24 Reduced 0.31%	7,758 $713,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $1,920 - $2,227	-24 Reduced 0.31%	7,758 $713,000
Q4 2022 Dec 13, 2023	SELL	$75.55 - $92.52 $30,975 - $37,933	-410 Reduced 5.0%	7,782 $705,000
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $30,975 - $37,933	-410 Reduced 5.0%	7,782 $705,000
Q3 2022 Dec 13, 2023	SELL	$74.61 - $87.26 $10,072 - $11,780	-135 Reduced 1.62%	8,192 $622,000
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $10,072 - $11,780	-135 Reduced 1.62%	8,192 $623,000
Q2 2022 Dec 13, 2023	BUY	$80.52 - $93.75 $365,077 - $425,062	4,534 Added 119.54%	8,327 $703,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $365,077 - $425,062	4,534 Added 119.54%	8,327 $704,000
Q1 2022 Dec 13, 2023	SELL	$80.11 - $90.62 $354,967 - $401,537	-4,431 Reduced 53.88%	3,793 $332,000
Q1 2022 May 17, 2022	BUY	$80.11 - $90.62 $303,857 - $343,721	3,793 New	3,793 $334,000
Q1 2019 May 18, 2021	SELL	$75.32 - $86.15 $321,691 - $367,946	-4,271 Closed	0 $0
Q4 2018 May 18, 2021	SELL	$73.66 - $82.02 $89,570 - $99,736	-1,216 Reduced 22.16%	4,271 $366,000
Q3 2018 May 18, 2021	SELL	$66.94 - $77.43 $6,292 - $7,278	-94 Reduced 1.68%	5,487 $474,000
Q2 2018 May 18, 2021	BUY	$64.91 - $73.36 $51,603 - $58,321	795 Added 16.61%	5,581 $422,000
Q1 2018 May 18, 2021	SELL	$70.39 - $84.15 $5,631 - $6,732	-80 Reduced 1.64%	4,786 $387,000
Q4 2017 May 18, 2021	BUY	$72.33 - $77.64 $16,346 - $17,546	226 Added 4.87%	4,866 $409,000
Q3 2017 May 18, 2021	BUY	$74.14 - $77.27 $9,934 - $10,354	134 Added 2.97%	4,640 $398,000
Q2 2017 May 18, 2021	BUY	N/A	748 Added 19.9%	4,506 $376,000
Q1 2017 May 18, 2021	BUY	N/A	3,758	3,758 $279,000

Others Institutions Holding NVS

# of Institutions

1,487

Shares Held

131M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.

Account

Continuum Advisory, LLC Novartis Ag Transaction History